Clinical Trial Update: Palmitoylethanolamide for Chronic Inflammatory Pain Conditions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for palmitoylethanolamide in chronic inflammatory pain conditions is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: Navy Medical Center San Diego | Conditions: Chronic Pain | Phase 2 | Status: RECRUITING